These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38584104)

  • 1. [Value of constructing a non-invasive diagnostic model based on serum heme oxygenase-1 and glucose regulatory protein 78 for non-alcoholic fatty liver disease].
    Cao JC; Zhang HK; Liu CM; Zhao SS; Nan YM; Li DD
    Zhonghua Gan Zang Bing Za Zhi; 2024 Mar; 32(3):228-234. PubMed ID: 38584104
    [No Abstract]   [Full Text] [Related]  

  • 2. [Application of heme oxygenase 1 in the diagnosis of non-alcoholic fatty liver disease].
    Yuan XW; Li DD; Liu LD; Zhang Y; Zhao W; Cui LY; Yang Y; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):291-297. PubMed ID: 31082341
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].
    Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simpler diagnostic formula for screening nonalcoholic fatty liver disease.
    Feng G; He N; Zhou YF; Li XP; Niu C; Liu ML; Zhang KL; Li Y; Li YM; Zheng MH; Mi M
    Clin Biochem; 2019 Feb; 64():18-23. PubMed ID: 30503530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on plasma Golgi protein 73 and related models in the diagnosis of nonalcoholic fatty liver disease].
    Wang YQ; Yuan XW; Li DD; Tang YH; Xue NN; Cui LY; Liu LD; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1170-1176. PubMed ID: 35045632
    [No Abstract]   [Full Text] [Related]  

  • 6. [Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].
    Xia B; He H; Qin K; Li SQ; An ZM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):591-595. PubMed ID: 37248589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
    Wang W; Shi LP; Shi L; Xu L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study.
    Qian Y; Sun B; Zhang Y; Zhang M; Jiao X; Lai L; Yang W
    Ann Palliat Med; 2022 Jul; 11(7):2349-2359. PubMed ID: 35542976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the effect of liraglutide on the correlation between NLRP3 inflammasome and non-alcoholic fatty liver disease].
    Ma ZZ; Ao N; Yang N; Yang J; Jin S; Du C; Du J
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):624-630. PubMed ID: 36038324
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease].
    Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India.
    Nigam P; Bhatt SP; Misra A; Vaidya M; Dasgupta J; Chadha DS
    PLoS One; 2013; 8(1):e49286. PubMed ID: 23326306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
    Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
    Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of multiple lipid and lipoprotein ratios with nonalcoholic fatty liver disease in patients with newly diagnosed type 2 diabetic mellitus: A retrospective study.
    Li R; Kong D; Ye Z; Zong G; Hu K; Xu W; Fang P; Zhang L; Zhou Y; Zhang K; Xue Y
    Front Endocrinol (Lausanne); 2023; 14():1127134. PubMed ID: 36875464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of reactive oxygen species and adiponectin for chronic HBV infection combined with nonalcoholic fatty liver diseases].
    Xu L; Zhong Y; Su ST; Liu YG; Lyu FN; Zhou XL; Ren JQ; Li P; Shi RF; Jiang Y; Fan JG; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):247-253. PubMed ID: 32306658
    [No Abstract]   [Full Text] [Related]  

  • 18. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population.
    Lu S; Kuang M; Yue J; Hu C; Sheng G; Zou Y
    Lipids Health Dis; 2022 Oct; 21(1):95. PubMed ID: 36207744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients.
    Zhao J; Fan H; Wang T; Yu B; Mao S; Wang X; Zhang W; Wang L; Zhang Y; Ren Z; Liang B
    Cardiovasc Diabetol; 2022 Jul; 21(1):123. PubMed ID: 35778734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels.
    Zhu W; Shi P; Fu J; Liang A; Zheng T; Wu X; Yuan S
    Lipids Health Dis; 2022 Dec; 21(1):149. PubMed ID: 36585668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.